NASDAQ:PANA Panacea Acquisition Corp. II (PANA) Stock Price, News & Analysis → The #1 Biotech Stock to Have on Your Radar in 2024… (From Huge Alerts) (Ad) Free PANA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.24▼$10.5650-Day Range$10.16▼$10.2552-Week Range$9.69▼$10.92Volume114,300 shsAverage Volume115,008 shsMarket Capitalization$241.15 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Panacea Acquisition Corp. II alerts: Email Address Ad Huge AlertsThe #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now! About Panacea Acquisition Corp. IIPanacea Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology sector. The company was incorporated in 2021 and is based in San Francisco, California.Read More Ad Huge AlertsThe #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now! PANA Stock News HeadlinesMarch 14, 2024 | benzinga.comNina S Kjellson's Net WorthNovember 20, 2023 | markets.businessinsider.comMayfair Acquisition Corp. and Boa Gold Corp. Enter into Definitive Agreement for Proposed Qualifying TransactionApril 24, 2024 | Huge Alerts (Ad)The #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!October 17, 2023 | msn.comAncora pushes Forward Air to scrap planned $3.2 billion Omni acquisitionSeptember 18, 2023 | markets.businessinsider.comFTAC EMERALD ACQUISITION CORP. ANNOUNCES POSTPONEMENT OF SPECIAL MEETING IN LIEU OF ANNUAL MEETING OF STOCKHOLDERSSeptember 15, 2023 | fool.comGlobal Partner Acquisition Corp II (NASDAQ: GPAC)August 25, 2023 | wsj.comLakeshore Acquisition II Corp.December 28, 2022 | bizjournals.comYear in Review: Houston-based fintech co. Qenta merging with SPAC was a Deal of the WeekApril 24, 2024 | Huge Alerts (Ad)The #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!December 13, 2022 | benzinga.comVenus Acquisition Corporation Announces Closing of Business Combination; MicroAlgo Inc. to trade on Nasdaq under the Symbol "MLGO".September 26, 2022 | benzinga.comPanacea Acquisition Corp. II Insider Trading ActivtySeptember 15, 2022 | apnews.comThe Channel Company Acquires The Confer GroupAugust 1, 2022 | bizjournals.comDavid Hung's Nuvation to cut 30 jobs, end cancer drug programMay 28, 2022 | news.yahoo.comPutin could be charged with the crime of aggression for the Ukraine war – but it's an expensive process with high stakesMarch 3, 2022 | msn.comPanacea Biotec shares hit upper circuit in early trade, here's whyAugust 8, 2021 | finance.yahoo.comPanacea Acquisition Corp. II (PANA)See More Headlines Receive PANA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Panacea Acquisition Corp. II and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:PANA CUSIPN/A CIK1828989 Webpanacea.ecor1cap.com PhoneN/AFaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$1.43 million Net MarginsN/A Pretax MarginN/A Return on Equity-24.09% Return on Assets0.82% Debt Debt-to-Equity RatioN/A Current Ratio0.48 Quick Ratio0.48 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.06 per share Price / Cash Flow169.00 Book Value($0.27) per share Price / Book-37.93Miscellaneous Outstanding Shares23,550,000Free FloatN/AMarket Cap$241.15 million OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Oleg Nodelman (Age 45)Chairman & CEO Mr. Scott Eric Perlen (Age 47)Chief Financial Officer Mr. Scott Platshon (Age 31)Chief Operating Officer Ms. Caroline Stout (Age 31)Chief Investment Officer Ms. Sarah Marriott (Age 45)Sec. & Director Key CompetitorsPlum Acquisition Corp. IIINASDAQ:PLMJCartesian Growth Co. IINASDAQ:RENEGlobal Consumer AcquisitionNASDAQ:GACQSpring Valley Acquisition Corp. IINASDAQ:SVIIKensington Capital Acquisition Corp. IINYSE:KCACView All Competitors PANA Stock Analysis - Frequently Asked Questions When did Panacea Acquisition Corp. II IPO? Panacea Acquisition Corp. II (PANA) raised $150 million in an IPO on Wednesday, April 7th 2021. The company issued 15,000,000 shares at $10.00 per share. Cowen acted as the underwriter for the IPO. This page (NASDAQ:PANA) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panacea Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
